Evidence map›Paper›PMID 28263038›Full record

ArticleEnvironmental microbiology2017

Divide and conquer: the Pseudomonas aeruginosa two-component hybrid SagS enables biofilm formation and recalcitrance of biofilm cells to antimicrobial agents via distinct regulatory circuits.

Olga E Petrova, Kajal Gupta, Julie Liao, James S Goodwine, Karin Sauer

Abstract read
In one paragraph

Article in Environmental microbiology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed.

  1. Efficacy of peracetic acid and chlorine in managingApplied and environmental microbiology · 2026
    Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Review
  11. Article
  12. Controlling Biofilm Development Through Cyclic di-GMP Signaling.Advances in experimental medicine and biology · 2022
    Review
  13. Role of Two-Component System Networks in Pseudomonas aeruginosa Pathogenesis.Advances in experimental medicine and biology · 2022
    Article
  14. Article
  15. Review
  16. Article
  17. Review
  18. Biofilm dispersion.Nature reviews. Microbiology · 2020
    Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Olga E PetrovaDepartment of Biological Sciences, Binghamton Biofilm Research Center, Binghamton University, Binghamton, NY, 13902, USA.
Kajal GuptaDepartment of Biological Sciences, Binghamton Biofilm Research Center, Binghamton University, Binghamton, NY, 13902, USA.
Julie LiaoDepartment of Biological Sciences, Binghamton Biofilm Research Center, Binghamton University, Binghamton, NY, 13902, USA.
James S GoodwineDepartment of Biological Sciences, Binghamton Biofilm Research Center, Binghamton University, Binghamton, NY, 13902, USA.
Karin SauerDepartment of Biological Sciences, Binghamton Biofilm Research Center, Binghamton University, Binghamton, NY, 13902, USA.

Funding

Role of PA4878 in biofilm antimicrobial resistanceR01AI080710 · NIAID · STATE UNIVERSITY OF NY,BINGHAMTON · PI LAU, GEE W, SAUER, KARIN · 2009 to 2020
$3.1M
Role of SagS signaling and regulatory events in biofilm formation and toleranceR21AI119726 · NIAID · STATE UNIVERSITY OF NY,BINGHAMTON · PI SAUER, KARIN · 2015 to 2016
$426k
NIAID NIH HHS R01 AI080710NIAID NIH HHS R21 AI119726
6 · The paper itself

Abstract

The opportunistic pathogen Pseudomonas aeruginosa forms antimicrobial resistant biofilms through sequential steps requiring several two-component regulatory systems. The sensor-regulator hybrid SagS plays a central role in biofilm development by enabling the switch from the planktonic to the biofilm mode of growth, and by facilitating the transition of biofilm cells to a highly tolerant state. However, the mechanism by which SagS accomplishes both functions is unknown. SagS harbours a periplasmic sensory HmsP, and phosphorelay HisKA and Rec domains. SagS domain was used as constructs and site-directed mutagenesis to elucidate how SagS performs its dual functions. It was demonstrated that HisKA-Rec and the phospho-signalling between SagS and BfiS contribute to the switch to the biofilm mode of growth, but not to the tolerant state. Instead, expression of SagS domain constructs harbouring HmsP rendered ΔsagS biofilm cells as recalcitrant to antimicrobial agents as wild-type biofilms, likely by restoring BrlR production and cellular c-di-GMP levels to wild-type levels. Restoration of biofilm tolerance by HmsP was independent of biofilm biomass accumulation, RsmA, RsmYZ, HptB and BfiSR-downstream targets. Our findings thus suggest that SagS likely makes use of a "divide-and-conquer" mechanism to regulate its dual switch function, by activating two distinct regulatory networks via its individual domains.

Indexed as

Anti-Bacterial AgentsBacterial ProteinsBiofilmsCyclic GMPDrug Resistance, Multiple, BacterialGene Expression Regulation, BacterialHistidine KinaseMutagenesis, Site-DirectedProtein DomainsPseudomonas aeruginosaSignal TransductionAnti-Bacterial AgentsBacterial Proteinsbis(3',5')-cyclic diguanylic acidCyclic GMPHistidine Kinase

Identifiers

PMID28263038
PMCPMC5702475

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.